{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:31Z","timestamp":1791214051404,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.2119\/2006-00085.baechler","type":"journal-article","created":{"date-parts":[[2007,11,20]],"date-time":"2007-11-20T13:38:56Z","timestamp":1195565936000},"page":"59-68","source":"Crossref","is-referenced-by-count":283,"title":["An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity"],"prefix":"10.1186","volume":"13","author":[{"given":"Emily C.","family":"Baechler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ward A.","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Espe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Novitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Ytterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,1]]},"reference":[{"key":"1301059_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA. (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum. Dis. Clin. North. Am. 28:723\u201341.","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"1301059_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00002281-200109000-00015","volume":"13","author":"AM Reed","year":"2001","unstructured":"Reed AM. (2001) Myositis in children. Curr. Opin. Rheumatol. 13:428\u201333.","journal-title":"Curr. Opin. Rheumatol."},{"key":"1301059_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","volume":"84","author":"TP O\u2019Hanlon","year":"2005","unstructured":"O\u2019Hanlon TP et al. (2005) Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore). 84:338\u201349.","journal-title":"Medicine (Baltimore)"},{"key":"1301059_CR4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/art.1780291109","volume":"29","author":"ML Christensen","year":"1986","unstructured":"Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM. (1986) Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum. 29:1365\u201370.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR5","first-page":"664","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA et al. (2005) Interferon-alpha\/betamediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57:664\u201378.","journal-title":"Neurol"},{"key":"1301059_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","volume":"59","author":"SA Greenberg","year":"2002","unstructured":"Greenberg SA et al. (2002) Molecular profiles of inflammatory myopathies. Neurology. 59:1170\u201382.","journal-title":"Neurology"},{"key":"1301059_CR7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awh518","volume":"128","author":"R Raju","year":"2005","unstructured":"Raju R, Dalakas MC. (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain. 128:1887\u201396.","journal-title":"Brain"},{"key":"1301059_CR8","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","volume":"168","author":"Z Tezak","year":"2002","unstructured":"Tezak Z et al. (2002) Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J. Immunol. 168:4154\u201363.","journal-title":"J. Immunol."},{"key":"1301059_CR9","first-page":"BR191","volume":"10","author":"X Zhou","year":"2004","unstructured":"Zhou X, Dimachkie MM, Xiong M, Tan FK, Arnett FC. (2004) cDNAmicroarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies. Med. Sci. Monit. 10:BR191\u20137.","journal-title":"Med. Sci. Monit."},{"key":"1301059_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.coi.2004.09.014","volume":"16","author":"EC Baechler","year":"2004","unstructured":"Baechler EC, Gregersen PK, Behrens TW. (2004) The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16:801\u20137.","journal-title":"Curr. Opin. Immunol."},{"key":"1301059_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/art.21571","volume":"54","author":"L Ronnblom","year":"2006","unstructured":"Ronnblom L, Eloranta ML, Alm GV. (2006) The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54:408\u201320.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR12","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100:2610\u20135.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1301059_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711\u201323.","journal-title":"J. Exp. Med."},{"key":"1301059_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/08916930310001625952","volume":"36","author":"MK Crow","year":"2003","unstructured":"Crow MK, Kirou KA, Wohlgemuth J. (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity. 36:481\u201390.","journal-title":"Autoimmunity"},{"key":"1301059_CR15","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/ard.2004.033753","volume":"64","author":"MC Dall\u2019era","year":"2005","unstructured":"Dall\u2019era MC, Cardarelli PM, Preston BT, Witte A, Davis JC Jr. (2005) Type I interferon correlates with serological and clinical manifestations of SLE. Ann. Rheum. Dis. 64:1692\u20137.","journal-title":"Ann. Rheum. Dis."},{"key":"1301059_CR16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.21031","volume":"52","author":"KA Kirou","year":"2005","unstructured":"Kirou KA et al. (2005) Activation of the interferonalpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52:1491\u2013503.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR17","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1172\/JCI200419139","volume":"113","author":"KS Peterson","year":"2004","unstructured":"Peterson KS et al. (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113:1722\u201333.","journal-title":"J. Clin. Invest."},{"key":"1301059_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","volume":"159","author":"L Farkas","year":"2001","unstructured":"Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. (2001) Plasmacytoid dendritic cells (natural interferon alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:237\u201343.","journal-title":"Am. J. Pathol."},{"key":"1301059_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1191\/096120301678416042","volume":"10","author":"S Blomberg","year":"2001","unstructured":"Blomberg S et al. (2001) Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 10:484\u201390.","journal-title":"Lupus"},{"key":"1301059_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0105-2896.2006.00367.x","volume":"210","author":"EC Baechler","year":"2006","unstructured":"Baechler EC et al. (2006) Gene expression profiling in human autoimmunity. Immunol. Rev. 210:120\u201337.","journal-title":"Immunol. Rev."},{"key":"1301059_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. (1975) Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292:344\u20137.","journal-title":"N. Engl. J. Med."},{"key":"1301059_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. (1975) Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292:403\u20137.","journal-title":"N. Engl. J. Med."},{"key":"1301059_CR23","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.20179","volume":"50","author":"AM Huber","year":"2004","unstructured":"Huber AM et al. (2004) Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 50:1595\u2013603.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR24","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/art.21291","volume":"52","author":"CV Oddis","year":"2005","unstructured":"Oddis CV et al. (2005) International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 52:2607\u201315.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/art.1780340802","volume":"34","author":"M Petri","year":"1991","unstructured":"Petri M, Genovese M, Engle E, Hochberg M. (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis. Rheum. 34:937\u201344.","journal-title":"Arthritis. Rheum."},{"key":"1301059_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y. (1990) More powerful procedures for multiple significance testing. Stat. Med. 9:811\u20138.","journal-title":"Stat. Med."},{"key":"1301059_CR27","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"V Tusher","year":"2001","unstructured":"Tusher V, Tibshirani R, Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116\u201321.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1301059_CR28","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","volume":"95","author":"MB Eisen","year":"1998","unstructured":"Eisen MB, Spellman PT, Brown PO, Botstein D. (1998) Cluster analysis and display of genomewide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:14863\u20138.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1301059_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2119\/2006-00003.Gulko","volume":"11","author":"FM Batliwalla","year":"2005","unstructured":"Batliwalla FM et al. (2005) Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol. Med. 11:21\u20139.","journal-title":"Mol. Med."},{"key":"1301059_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00439-002-0812-5","volume":"111","author":"S Semprini","year":"2002","unstructured":"Semprini S et al. (2002) Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum. Genet. 111:310\u20133.","journal-title":"Hum. Genet."},{"key":"1301059_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/sj.gene.6364209","volume":"6","author":"FM Batliwalla","year":"2005","unstructured":"Batliwalla FM et al. (2005) Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 6:388\u201397.","journal-title":"Genes Immun."},{"key":"1301059_CR32","first-page":"368","volume":"22","author":"A Schulze Wiesch zur","year":"2004","unstructured":"Schulze zur Wiesch A et al. (2004) Myeloid related proteins MRP8\/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22:368\u201373.","journal-title":"Clin. Exp. Rheumatol."},{"key":"1301059_CR33","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2337\/diabetes.53.8.1979","volume":"53","author":"G Bouma","year":"2004","unstructured":"Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. (2004) Increased serum levels of MRP-8\/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes. 53:1979\u201386.","journal-title":"Diabetes"},{"key":"1301059_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.0105-2896.2005.00219.x","volume":"204","author":"SL Kalled","year":"2005","unstructured":"Kalled SL. (2005) The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev. 204:43\u201354.","journal-title":"Immunol. Rev."},{"key":"1301059_CR35","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","volume":"173","author":"GW Nelson","year":"2004","unstructured":"Nelson GW et al. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J. Immunol. 173:4273\u20136.","journal-title":"J. Immunol."},{"key":"1301059_CR36","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.2337\/diabetes.52.10.2639","volume":"52","author":"AR Slik van der","year":"2003","unstructured":"van der Slik AR et al. (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes. 52:2639\u201342.","journal-title":"Diabetes"},{"key":"1301059_CR37","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/art.10566","volume":"46","author":"M Massa","year":"2002","unstructured":"Massa M et al. (2002) Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum. 46:3015\u201325.","journal-title":"Arthritis Rheum."},{"key":"1301059_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/clin.1998.4527","volume":"87","author":"DS Tews","year":"1998","unstructured":"Tews DS, Goebel HH. (1998) Cell death and oxidative damage in inflammatory myopathies. Clin. Immunol. Immunopathol. 87:240\u20137.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"1301059_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.it.2004.05.001","volume":"25","author":"A Perl","year":"2004","unstructured":"Perl A, Gergely P Jr., Nagy G, Koncz A, Banki K. (2004) Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25: 360\u20137.","journal-title":"Trends Immunol."},{"key":"1301059_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:1529\u201331.","journal-title":"Science"},{"key":"1301059_CR41","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:1526\u20139.","journal-title":"Science"},{"key":"1301059_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi H et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature. 408:740\u20135.","journal-title":"Nature"},{"key":"1301059_CR43","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.4049\/jimmunol.165.6.3519","volume":"165","author":"U Bave","year":"2000","unstructured":"Bave U, Alm GV, Ronnblom L. (2000) The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J. Immunol. 165:3519\u201326.","journal-title":"J. Immunol."},{"key":"1301059_CR44","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/art.20254","volume":"50","author":"T Lovgren","year":"2004","unstructured":"Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis. Rheum. 50:1861\u201372.","journal-title":"Arthritis. Rheum."},{"key":"1301059_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"R Graham","year":"2006","unstructured":"Graham R et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38:550\u20135.","journal-title":"Nat. Genet."},{"key":"1301059_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/428480","volume":"76","author":"S Sigurdsson","year":"2005","unstructured":"Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76:528\u201337.","journal-title":"Am. J. Hum. Genet."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/2006-00085.Baechler","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/2006-00085.Baechler.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:19:35Z","timestamp":1554509975000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/2006-00085.Baechler"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["1301059"],"URL":"https:\/\/doi.org\/10.2119\/2006-00085.baechler","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}